We then used gene set enrichment analysis (GSEA) to test whether specific myeloid signatures recently identified by scRNAseq13 were differentially expressed in microglia cells exposed to GBM cells expressing ZBTB18. The gene discussed is ZBTB18; the disease is glioblastoma.